Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJMBR (3) BJPS (1) Autor Alencar,M.C.N. (1) Arbex,F.F. (1) Borghi-Silva,A. (1) Bu,J.Y. (1) Chen,L.L. (1) Feng,Wei (1) Hong,H.S. (1) Hua,C.Y. (1) Huang,Y. (1) Li,Y.H. (1) Lin,X.H. (1) Ling,Yesheng (1) Mazzuco,A. (1) Medeiros,W.M. (1) Neder,J.A. (1) Pan,Sinian (1) Souza,A.S. (1) Sperandio,P.A. (1) Su,Y.H. (1) Tang,Leile (1) Mais... Palavra-chave Chronic heart failure (4) Aldosterone (1) Aldosterone synthase (1) Cardiac function (1) Chronic obstructive pulmonary disease (1) Collaborative care model (1) Exercise test (1) Heart rate (1) Oxygen uptake (1) Quality of life (1) Recombinant human brain natriuretic peptide (1) Recovery kinetics (1) Salidroside/protective effects (1) Self-care (1) Mais... Tipo do documento Info:eu-repo/semantics/article (4) Ano 2020 (1) 2019 (1) 2017 (1) 2014 (1) País Brazil (4) Idioma Inglês (4)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 4 Primeira ... 1 ... Última Effects of high- and moderate-intensity exercise on central hemodynamic and oxygen uptake recovery kinetics in CHF-COPD overlap BJMBR Mazzuco,A.; Souza,A.S.; Medeiros,W.M.; Sperandio,P.A.; Alencar,M.C.N.; Arbex,F.F.; Neder,J.A.; Borghi-Silva,A.. The oxygen uptake (V˙O2) kinetics during onset of and recovery from exercise have been shown to provide valuable parameters regarding functional capacity of both chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) patients. To investigate the influence of comorbidity of COPD in patients with CHF with reduced ejection fraction on recovery from submaximal exercise, 9 CHF-COPD male patients and 10 age-, gender-, and left ventricle ejection fraction (LVEF)-matched CHF patients underwent constant-load exercise tests (CLET) at moderate and high loads. The V˙O2, heart rate (HR), and cardiac output (CO) recovery kinetics were determined for the monoexponential relationship between these variables and time. Within-group analysis showed that... Tipo: Info:eu-repo/semantics/article Palavras-chave: Chronic heart failure; Chronic obstructive pulmonary disease; Oxygen uptake; Heart rate; Recovery kinetics; Exercise test. Ano: 2020 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2020000300602 Collaborative care model improves self-care ability, quality of life and cardiac function of patients with chronic heart failure BJMBR Hua,C.Y.; Huang,Y.; Su,Y.H.; Bu,J.Y.; Tao,H.M.. Chronic heart failure (CHF) is a common chronic disease that requires much care. This study aimed to explore the effects of collaborative care model (CCM) on patients with CHF. A total of 114 CHF patients were enrolled in this study, and were randomly and equally divided into two groups: control and experimental. Patients in the two groups received either usual care or CCM for 3 continuous months. The impacts of CCM on the self-care ability and quality of life were assessed using self-care of heart failure index and short form health survey 12, respectively. Further, cardiac function was assessed by measuring left ventricular ejection fraction (LVEF) and the level of N-terminal pro-B-type natriuretic peptide (NT-proBNP), and by the 6-min walking test.... Tipo: Info:eu-repo/semantics/article Palavras-chave: Collaborative care model; Chronic heart failure; Self-care; Quality of life; Cardiac function. Ano: 2017 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017001100609 Changes in cardiac aldosterone and its synthase in rats with chronic heart failure: an intervention study of long-term treatment with recombinant human brain natriuretic peptide BJMBR Zhu,X.Q.; Hong,H.S.; Lin,X.H.; Chen,L.L.; Li,Y.H.. The physiological mechanisms involved in isoproterenol (ISO)-induced chronic heart failure (CHF) are not fully understood. In this study, we investigated local changes in cardiac aldosterone and its synthase in rats with ISO-induced CHF, and evaluated the effects of treatment with recombinant human brain natriuretic peptide (rhBNP). Sprague-Dawley rats were divided into 4 different groups. Fifty rats received subcutaneous ISO injections to induce CHF and the control group (n=10) received equal volumes of saline. After establishing the rat model, 9 CHF rats received no further treatment, rats in the low-dose group (n=8) received 22.5 μg/kg rhBNP and those in the high-dose group (n=8) received 45 μg/kg rhBNP daily for 1 month. Cardiac function was assessed... Tipo: Info:eu-repo/semantics/article Palavras-chave: Chronic heart failure; Aldosterone; Aldosterone synthase; Recombinant human brain natriuretic peptide. Ano: 2014 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2014000800646 Protective effects of salidroside on chronic heart failure in rats and the underlying mechanisms BJPS Zhang,Chengxi; Pan,Sinian; Tang,Leile; Ling,Yesheng; Zhou,Xiaojing; Feng,Wei. The present study aimed to investigate the protective effects of salidroside on chronic heart failure (CHF) in rats and to explore the underlying mechanisms. One hundred SD rats were randomly divided into sham-operated, model, and low-, medium- and high-dose salidroside groups. The CHF model was established in later 4 groups. The later 3 groups were intragastrically administrated with 6, 12 and 24 mg/kg salidroside, respectively, once a day, for continuous 4 weeks. Finally, the serum levels of brain natriuretic peptide (BNP) and interleukin 6 (IL-6), cardiac function indexes, and expression levels of myocardial cysteinyl aspartate-specific proteinase (Caspase)-3, Caspase-9, matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase-1... Tipo: Info:eu-repo/semantics/article Palavras-chave: Salidroside/protective effects; Chronic heart failure. Ano: 2019 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502019000100517 Registros recuperados: 4 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco